secwatch.observer — SEC 8-K summary
======================================

Issuer:     ImageneBio, Inc. (IMA)
CIK:        0001835579
Form:       8-K
Filed at:   2022-06-10T23:59:59+00:00
Accession:  0001193125-22-171517
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Ikena Oncology shareholders elect three Class I directors and ratify EY as auditor
--------------------------------------------------------------------------------

- Elected Iain D. Dukes (23.9M for), Maria Koehler (24.6M for), Otello Stampacchia (23.3M for) to 3-year terms.
- Ratified Ernst & Young as independent auditor for FY 2022 with 28.5M votes for, 1,095 against.
- Meeting held June 9, 2022; all stockholder proposals passed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835579/000119312522171517/0001193125-22-171517-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835579/000119312522171517/d322633d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-171517

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer